Immunological network signatures of cancer progression and survival

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Clancy, Trevor ^a   Pedicini, Marco ^b   Castiglione, Filippo ^b   Santoni, Daniele ^b   Nygaard, Vegard ^a   Lavelle, Timothy J ^a   Benson, Mikael ^c   Hovig, Eivind ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b CNR   (Italy)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CALGRANULIN A; CALGRANULIN B; CD14 ANTIGEN; CD24 ANTIGEN; CD31 ANTIGEN; CD40 ANTIGEN; CD8ALPHA ANTIGEN; CHEMOKINE RECEPTOR CCR5; CXCL13 CHEMOKINE; DECAY ACCELERATING FACTOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 24; INTERLEUKIN 26; INTERLEUKIN 7; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BAX; STAT4 PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR PIT 1; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HUMAN; MELANOMA; MOLECULAR INTERACTION; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN INTERACTION; QUALITY CONTROL; SCORING SYSTEM; SYSTEMATIC REVIEW; TUMOR IMMUNITY; UPREGULATION; ANTIBODY SPECIFICITY; BIOLOGY; DISEASE COURSE; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; METHODOLOGY; NEOPLASM; PATHOLOGY; SURVIVAL RATE; TUMOR GENE;

BENCHMARKING; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENES, NEOPLASM; HUMANS; IMMUNE SYSTEM; MELANOMA; NEOPLASMS; ORGAN SPECIFICITY; PROGNOSIS; SURVIVAL RATE;

EID: 79953199091     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-28     Document Type: Article

References (54)

1. RL Virchow, Die Krankhaften Geschwülste Dreissig Vorlesungen gehalten während des Wintersemesters 1862-63 Vierte Vorlesung Berlin 1863 1 65
2. Cancer-related inflammation. A Mantovani P Allavena A Sica F Balkwill, Nature 2008 454 436 444 10.1038/nature07205 18650914
3. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome. J Galon, Science 2006 313 1960 1964 10.1126/science.1129139 17008531 (Pubitemid 44498003)
4. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. SS Dave G Wright B Tan A Rosenwald RD Gascoyne WC Chan RI Fisher RM Braziel LM Rimsza TM Grogan, et al. N Engl J Med 2004 351 2159 2169 10.1056/NEJMoa041869 15548776 (Pubitemid 39507628)
5. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. D Bogunovic DW O'Neill I Belitskaya-Levy V Vacic YL Yu S Adams F Darvishian R Berman R Shapiro AC Pavlick, et al. Proc Natl Acad Sci USA 2009 106 20429 20434 10.1073/pnas. 0905139106 19915147
6. Immune Regulation of Cancer. ML Disis, Journal of Clinical Oncology 2010
7. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. L Zhang JR Conejo-Garcia D Katsaros PA Gimotty M Massobrio G Regnani A Makrigiannakis H Gray K Schlienger MN Liebman, et al. N Engl J Med 2003 348 203 213 10.1056/NEJMoa020177 12529460 (Pubitemid 36077915)
8. Navigating the network: signaling cross-talk in hematopoietic cells. IDC Fraser RN Germain, Nat Immunol 2009 10 327 331 10.1038/ni.1711 19295628
9. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. B Mlecnik M Tosolini P Charoentong A Kirilovsky G Bindea A Berger M Camus M Gillard P Bruneval WH Fridman, et al. Gastroenterology 2010 138 4 1429 1440 10.1053/j.gastro.2009.10. 057 19909745
10. A prescription for human immunology. MM Davis, Immunity 2008 29 835 838 10.1016/j.immuni.2008.12.003 19100694
11. Tumor microenvironments, the immune system and cancer survival. RL Strausberg, Genome Biol 2005 6 211 10.1186/gb-2005-6-3-211 15774034
12. A global approach to tumor immunology. E Wang MC Panelli V Monsurró FM Marincola, Cell Mol Immunol 2004 1 256 265 16225768
13. Computational immunology: The coming of age. N Petrovsky V Brusic, Immunol Cell Biol 2002 80 248 254 10.1046/j.1440-1711.2002.01093.x 12067412 (Pubitemid 34639375)
14. Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction. B Mlecnik F Sanchez-Cabo P Charoentong G Bindea F Pagès A Berger J Galon Z Trajanoski, BMC Genomics 2010 11 Suppl 1 7 10.1186/1471-2164-11-S1-S7 20158878
15. Natural immunity to cancer in humans. G Bindea B Mlecnik WH Fridman F Pages J Galon, Curr Opin Immunol 2010 22 2 215 222 10.1016/j.coi.2010.02.006 20207124
16. Gene-expression profiling in vaccine therapy and immunotherapy for cancer. D Bedognetti E Wang MR Sertoli FM Marincola, Expert Rev Vaccines 2010 9 6 555 565 10.1586/erv.10.55 20518712
17. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. AI Riker SA Enkemann O Fodstad S Liu S Ren C Morris Y Xi P Howell B Metge RS Samant, et al. BMC Med Genomics 2008 1 13 10.1186/1755-8794-1-13 18442402
18. Gene Expression Profiling-Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome. GB Jonsson C Busch S Knappskog J Geisler H Miletic M Ringner JR Lillehaug A Borg PE Lonning, Clin Cancer Res 2010
19. A literature network of human genes for high-throughput analysis of gene expression. TK Jenssen A Laegreid J Komorowski E Hovig, Nat Genet 2001 28 21 28 11326270 (Pubitemid 32405811)
20. Immunome Knowledge Base (IKB): An integrated service for immunome research. C Ortutay M Vihinen, BMC Immunol 2009 10 3 10.1186/1471-2172-10-3 19134210
21. A network-based analysis of systemic inflammation in humans. SE Calvano W Xiao DR Richards RM Felciano HV Baker RJ Cho RO Chen BH Brownstein JP Cobb SK Tschoeke, et al. Nature 2005 437 1032 1037 10.1038/nature03985 16136080 (Pubitemid 41486985)
22. Assembly of inflammation-related genes for pathway-focused genetic analysis. MJ Loza CE Mccall L Li WB Isaacs J Xu BL Chang, PLoS ONE 2007 2 1035 10.1371/journal.pone.0001035 17940599
23. Scale-Free Networks: A Decade and Beyond. AL Barabasi, Science 2009 325 412 413 10.1126/science.1173299 19628854
24. A gene atlas of the mouse and human protein-encoding transcriptomes. AI Su T Wiltshire S Batalov H Lapp KA Ching D Block J Zhang R Soden M Hayakawa G Kreiman, et al. Proc Natl Acad Sci USA 2004 101 16 6062 6067 10.1073/pnas.0400782101 15075390 (Pubitemid 38520528)
25. Tissue specificity and the human protein interaction network. A Bossi B Lehner, Mol Syst Biol 2009 5 260 10.1038/msb.2009.17 19357639
26. Infections and human cancer. R Newton, Ann Oncol 2000 11 9 1081 1082 10.1023/A:1008302607206 11061599
27. Inflammation and cancer: back to Virchow? F Balkwill A Mantovani, Lancet 2001 357 539 545 10.1016/S0140-6736(00)04046-0 11229684 (Pubitemid 32173595)
28. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. F Balkwill KA Charles A Mantovani, Cancer Cell 2005 7 211 217 10.1016/j.ccr.2005.02.013 15766659 (Pubitemid 40568680)
29. Cellular and molecular pathways linking inflammation and cancer. C Porta P Larghi M Rimoldi M Grazia Totaro P Allavena A Mantovani A Sica, Immunobiology 2009 214 761 777 10.1016/j.imbio.2009.06.014 19616341
30. InnateDB: facilitating systems-level analyses of the mammalian innate immune response. DJ Lynn GL Winsor C Chan N Richard MR Laird A Barsky JL Gardy FM Roche THW Chan N Shah, et al. Mol Syst Biol 2008 4 1 11 10.1038/msb.2008.55
31. IRIS: a database surveying known human immune system genes. J Kelley B de Bono J Trowsdale, Genomics 2005 85 503 511 10.1016/j.ygeno.2005.01.009 15780753 (Pubitemid 40386479)
32. Curating the innate immunity interactome. DJ Lynn C Chan M Naseer M Yau R Lo A Sribnaia G Ring J Que K Wee GL Winsor, et al. BMC Syst Biol 2010 4 1 117 10.1186/1752-0509-4-117 20727158
33. Network biology: understanding the cell's functional organization. AL Barabsi ZN Oltvai, Nat Rev Genet 2004 5 101 113 14735121 (Pubitemid 38160277)
34. Global topological features of cancer proteins in the human interactome. PF Jonsson, Bioinformatics 2006 22 2291 2297 10.1093/bioinformatics/btl390 16844706 (Pubitemid 44390886)
35. Efficiency of the immunome protein interaction network increases during evolution. C Ortutay M Vihinen, Immunome Res 2008 4 4 10.1186/1745-7580-4-4 18430195
36. The biologic importance of tumor-infiltrating lymphocytes. FS Hodi G Dranoff, J Cutan Pathol 2010 37 Suppl 1 48 53 10.1111/j.1600-0560.2010.01506.x 20482675
37. Effector memory T cells, early metastasis, and survival in colorectal cancer. F Pagès A Berger M Camus F Sanchez-Cabo A Costes R Molidor B Mlecnik A Kirilovsky M Nilsson D Damotte, et al. N Engl J Med 2005 353 2654 2666 16371631 (Pubitemid 41817714)
38. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecnik C Lagorce-Pagès M Tosolini M Camus A Berger P Wind, et al. Science 2006 313 1960 1964 10.1126/science.1129139 17008531 (Pubitemid 44498003)
39. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. F Piras R Colombari L Minerba D Murtas C Floris C Maxia A Corbu MT Perra P Sirigu, Cancer 2005 104 1246 1254 10.1002/cncr.21283 16078259 (Pubitemid 41278960)
40. Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. IS van Houdt BJR Sluijter LM Moesbergen WM Vos TD de Gruijl BG Molenkamp AJM van den Eertwegh E Hooijberg PAM van Leeuwen CJLM Meijer, et al. Int J Cancer 2008 123 609 615 10.1002/ijc.23543 18498132 (Pubitemid 351898419)
41. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. E Sato SH Olson J Ahn B Bundy H Nishikawa F Qian AA Jungbluth D Frosina S Gnjatic C Ambrosone, et al. Proc Natl Acad Sci USA 2005 102 18538 18543 10.1073/pnas.0509182102 16344461 (Pubitemid 43011261)
42. Immune infiltration in human tumors: a prognostic factor that should not be ignored. F Pagès J Galon MC Dieu-Nosjean E Tartour C Sautès-Fridman WH Fridman, Oncogene 2010 29 1093 1102 19946335
43. Immune surveillance in the skin: mechanisms and clinical consequences. TS Kupper RC Fuhlbrigge, Nat Rev Immunol 2004 4 211 222 10.1038/nri1310 15039758 (Pubitemid 38339087)
44. Skin immune sentinels in health and disease. FO Nestle P Di Meglio JZ Qin BJ Nickoloff, Nat Rev Immunol 2009 9 679 691 19763149
45. Malignant melanoma: genetics and therapeutics in the genomic era. L Chin LA Garraway DE Fisher, Genes & Development 2006 20 2149 2182
46. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Eyles AL Puaux X Wang B Toh C Prakash M Hong TG Tan L Zheng LC Ong Y Jin, et al. J Clin Invest 2010 120 2030 2039 10.1172/JCI42002 20501944
47. Paradoxical roles of the immune system during cancer development. KE De Visser A Eichten LM Coussens, Nat Rev Cancer 2006 6 24 37 10.1038/nrc1782 16397525 (Pubitemid 43053650)
48. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. M Ashburner CA Ball JA Blake D Botstein H Butler JM Cherry AP Davis K Dolinski SS Dwight JT Eppig, et al. Nat Genet 2000 25 25 29 10.1038/75556 10802651 (Pubitemid 30257031)
49. A Mathematical Theory of Communication. CE Shannon, The Bell System Technical Journal 1948 379 423 623-656
50. Generalized Venn diagrams: a new method of visualizing complex genetic set relations. HA Kestler A Müller TM Gress M Buchholz, Bioinformatics 2005 21 1592 1595 10.1093/bioinformatics/bti169 15572472 (Pubitemid 40542716)
51. IntAct - open source resource for molecular interaction data. S Kerrien Y Alam-Faruque B Aranda I Bancarz A Bridge C Derow E Dimmer M Feuermann A Friedrichsen R Huntley, et al. Nucleic Acids Research 2007 35 561 565 10.1093/nar/gkl958 17145710
52. Human protein reference database as a discovery resource for proteomics. S Peri JD Navarro TZ Kristiansen R Amanchy V Surendranath B Muthusamy TKB Gandhi KN Chandrika N Deshpande S Suresh, et al. Nucleic Acids Research 2004 32 497 501 10.1093/nar/gkh070 14681466
53. Characterization of protein-interaction networks in tumors. A Platzer P Perco A Lukas B Mayer, BMC Bioinformatics 2007 8 224 10.1186/1471-2105-8-224 17597514
54. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. GK Smyth, Stat Appl Genet Mol Biol 2004 3 Article3 16646809